Expression and prognostic role of ubiquitination factor E4B in primary hepatocellular carcinoma

Molecular Carcinogenesis

Volumn 55, Issue 1, 2016, Pages 64-76

  Zhang, Xiao Fei ^a   Pan, Qiu Zhong ^a   Pan, Ke ^a   Weng, De Sheng ^a   Wang, Qi Jing ^a   Zhao, Jing Jing ^a   He, Jia ^a   Liu, Qing ^a   Wang, Dan Dan ^a   Jiang, Shan Shan ^a   Zheng, Hai Xia ^a   Lv, Lin ^a   Chen, Chang Long ^a   Zhang, Hong Xia ^a   Xia, Jian Chuan ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Apoptosis; Hepatocellular carcinoma; Oncogene; Prognosis; UBE4B

Indexed keywords

MESSENGER RNA; PROTEIN P53; SMALL INTERFERING RNA; UBIQUITIN; UBIQUITINATION FACTOR E4B; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; TUMOR SUPPRESSOR PROTEIN; UBE4B PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CANCER PROGNOSIS; CANCER TISSUE; CELL INVASION ASSAY; CELL MIGRATION ASSAY; CELL PROLIFERATION ASSAY; COLONY FORMATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER CELL; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UBIQUITINATION; UPREGULATION; WESTERN BLOTTING; CANCER GRADING; CANCER STAGING; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; GENE SILENCING; GENETICS; LIVER NEOPLASMS; METABOLISM; MIDDLE AGED; MORTALITY; PROGNOSIS; RISK FACTOR; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR VOLUME;

ADULT; AGED; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR BURDEN; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASE COMPLEXES;

EID: 84954228281     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22259     Document Type: Article

References (31)

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132:2557-2576.
2. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999; 49:33-64. 31.
3. Nakakura EK, Choti MA. Management of hepatocellular carcinoma. Oncology (Williston Park) 2000; 14:1085-1098. discussion1098-1102.
4. El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008; 134:1752-1763.
5. Hatakeyama S, Yada M, Matsumoto M, et al. U box proteins as a new family of ubiquitin-protein ligases. J Biol Chem 2001; 276:33111-33120.
6. Koegl M, Hoppe T, Schlenker S, et al. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 1999; 96:635-644.
7. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998; 67:425-479.
8. Johnson ES, Ma PC, Ota IM, Varshavsky A. A proteolytic pathway that recognizes ubiquitin as a degradation signal. J Biol Chem 1995; 270:17442-17456.
9. Kuhlbrodt K, Mouysset J, Hoppe T. Orchestra for assembly and fate of polyubiquitin chains. Essays Biochem 2005; 41:1-14.
10. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408:307-310.
11. Brown CJ, Lain S, Verma CS, et al. Awakening guardian angels: drugging the p53 pathway. Nat Rev Cancer 2009; 9:862-873.
12. Wu H, Pomeroy SL, Ferreira M, et al. UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53. Nat Med 2011; 17:347-355.
13. Wu H, Leng RP. UBE4B, a ubiquitin chain assembly factor, is required for MDM2-mediated p53 polyubiquitination and degradation. Cell Cycle 2011; 10:1912-1915.
14. Shi D, Pop MS, Kulikov R, et al. CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53. Proc Natl Acad Sci USA 2009; 106:16275-16280.
15. Heuze ML, Lamsoul I, Moog-Lutz C, Lutz PG. Ubiquitin-mediated proteasomal degradation in normal and malignant hematopoiesis. Blood Cells Mol Dis 2008; 40:200-210.
16. Zhang Y, Lv Y, Zhang Y, Gao H. Regulation of p53 level by UBE4B in breast cancer. PLoS ONE 2014; 9:e90154.
17. Hosoda M, Ozaki T, Miyazaki K, et al. UFD2a mediates the proteasomal turnover of p73 without promoting p73 ubiquitination. Oncogene 2005; 24:7156-7169.
18. Chatterjee A, Upadhyay S, Chang X, et al. U-box-type ubiquitin E4 ligase, UFD2a attenuates cisplatin mediated degradation of DeltaNp63alpha. Cell Cycle 2008; 7:1231-1237.
19. Broker LE, Kruyt FA, Giaccone G. Cell death independent of caspases: A review. Clin Cancer Res 2005; 11:3155-3162.
20. el-Deiry WS. Regulation of p53 downstream genes. Semin Cancer Biol 1998; 8:345-357.
21. Selvakumaran M, Lin HK, Miyashita T, et al. Immediate early up-regulation of bax expression by p53 but not TGF beta 1: A paradigm for distinct apoptotic pathways. Oncogene 1994; 9:1791-1798.
22. Ande SR, Chen J, Maddika S. The ubiquitin pathway: An emerging drug target in cancer therapy. Eur J Pharmacol 2009; 625:199-205.
23. Hochstrasser M. Ubiquitin-dependent protein degradation. Annu Rev Genet 1996; 30:405-439.
24. Jentsch S, Schlenker S. Selective protein degradation: a journey's end within the proteasome. Cell 1995; 82:881-884.
25. Scheffner M, Nuber U, Huibregtse JM. Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature 1995; 373:81-83.
26. Zage PE, Sirisaengtaksin N, Liu Y, et al. UBE4B levels are correlated with clinical outcomes in neuroblastoma patients and with altered neuroblastoma cell proliferation and sensitivity to epidermal growth factor receptor inhibitors. Cancer 2013; 119:915-923.
27. Caren H, Ejeskar K, Fransson S, et al. A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation. Mol Cancer 2005; 4:10.
28. Krona C, Ejeskar K, Abel F, et al. Screening for gene mutations in a 500kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2. Oncogene 2003; 22:2343-2351.
29. Yoo NJ, Park SW, Lee SH. Frameshift mutations of ubiquitination-related genes HERC2, HERC3, TRIP12, UBE2Q1 and UBE4B in gastric and colorectal carcinomas with microsatellite instability. Pathology 2011; 43:753-755.
30. Lefeuvre M, Gunduz M, Nagatsuka H, et al. Fine deletion analysis of 1p36 chromosomal region in oral squamous cell carcinomas. J Oral Pathol Med 2009; 38:94-98.
31. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74:609-619.